T. Rowe Price Associates’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$52.4M Buy
2025
Q1
$24.8M Buy
2024
Q4
$27.1M Buy
2024
Q3
$22.3M Sell
2024
Q2
$21M Sell
2024
Q1
$43.6M Buy